Table 1.
Baseline demographic characteristics in the mITT population
| Baseline demographic characteristics in mITT population | ||||
|---|---|---|---|---|
| No study drug | Favipiravir | Total | ||
| Total | 126 | 114 | 240 | |
| Site n (%) | Brazil site | 14 (11.1) | 16 (14.0) | 30 (12.5) |
| Thailand FTM site | 107 (84.9) | 96 (84.2) | 203 (84.6) | |
| Thailand Vajira site | 3 (2.4) | 2 (1.8) | 5 (2.1) | |
| Thailand Bangplee site | 2 (1.6) | 0 (0.0) | 2 (0.8) | |
| Age (years) | Mean (SD) | 30.0 (7.3) | 30.2 (7.5) | 30.1 (7.4) |
| Sex n (%) | Female | 81 (64.3) | 71 (62.3) | 152 (63.3) |
| Male | 45 (35.7) | 43 (37.7) | 88 (36.7) | |
| BMI (kg/m2) | Mean (SD) | 23.0 (3.8) | 23.1 (3.7) | 23.0 (3.8) |
| Weight (kg) | Mean (SD) | 62.8 (13.1) | 63.0 (13.6) | 62.9 (13.3) |
| Baseline viral load (log10 copies per mL) | Mean (SD) | 5.4 (1.2) | 5.5 (1.0) | 5.5 (1.1) |
| SARS-CoV-2 Variant/ subvariants | Delta | 10 (7.9) | 11 (9.6) | 21 (8.8) |
| BA. 1 | 15 (11.9) | 21 (18.4) | 36 (15.0) | |
| BA. 2 | 58 (46.0) | 47 (41.2) | 105 (43.8) | |
| BA. 3 | 1 (0.8) | 0 (0.0) | 1 (0.4) | |
| BA. 4 | 2 (1.6) | 3 (2.6) | 5 (2.1) | |
| BA. 5 | 40 (31.7) | 32 (28.1) | 72 (30.0) | |
| Symptoms duration (days) | Mean (SD) | 2.2 (0.8) | 2.1 (0.7) | 2.2 (0.7) |
| Vaccinated (%) | Yes | 122 (96.8) | 112 (98.2) | 234 (97.5) |
| No | 4 (3.2) | 2 (1.8) | 6 (2.5) | |